GlassScriptPhysician profile
Syed I Ali
NPI 1174636435
$15,160.29
in general payments reported to CMS, 2019-2025
39 companies · $1,473 in 2025
The $1,473 reported for 2025 was more than what 76% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,419 · 2020: $744 · 2021: $1,317 · 2022: $1,101 · 2023: $2,229 · 2024: $6,877 · 2025: $1,473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,500 · Food and Beverage: $4,343 · Travel and Lodging: $1,687 · Education: $49.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,500.00 |
| Food and Beverage | $4,342.74 |
| Travel and Lodging | $1,687.34 |
| Education | $49.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $6,042.32 | 2021-2025 | Osteocool Rf Ablation System, Kyphon Express II Kyphopak Tray, Inceptiv |
| Forte Bio-Pharma LLC | $1,204.57 | 2020-2025 | Prolate, Nalocet, Tanlor |
| Nevro Corp. | $1,179.12 | 2019-2024 | Senza |
| Boston Scientific Corporation | $1,146.06 | 2019-2024 | Varithena Administration Pack |
| Scilex Pharmaceuticals INC. | $967.68 | 2019-2025 | Ztlido |
| Collegium Pharmaceutical, INC. | $584.45 | 2020-2025 | Xtampza |
| Abbvie INC. | $500.72 | 2022-2025 | Botox, Ubrelvy, Qulipta |
| Pfizer INC. | $422.83 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $345.14 | 2023-2025 | Relistor |
| Zyla Life Sciences, INC. | $263.80 | 2019-2020 | |
| Arbor Pharmaceuticals, INC. | $246.49 | 2019-2022 | |
| Sentynl Therapeutics, INC. | $221.74 | 2019 | |
| Si-Bone, INC. | $204.27 | 2022-2025 | |
| Almatica Pharma LLC | $195.18 | 2021-2022 | |
| Biotronik Nro, INC. | $187.03 | 2024-2025 | Prospera |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Syed Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.